CELLECTAR BIOSCIENCES INC (CLRB)

US15117F8077 - Common Stock

0.235  0 (-1.26%)

After market: 0.238 +0 (+1.28%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/A
219.81%		N/A
272.13%		N/A
45.57%		N/A
32.41%		N/A
29.25%		N/A
-11.57%
EBITDA
YoY % growth
-10.88M-9.3M
14.52%		-8.2M
11.83%		-9.09M
-10.85%		-12.05M
-32.56%		-11.57M
3.98%		-14.05M
-21.43%		-15.16M
-7.90%		-23.98M
-58.18%		-28.66M
-19.52%		-38.768M
-35.27%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-11.3M-9.67M
14.42%		-8.56M
11.48%		-9.45M
-10.40%		-13.6M
-43.92%		-11.65M
14.34%		-14.18M
-21.72%		-15.3M
-7.90%		-24.13M
-57.71%		-28.81M
-19.39%		-38.961M
-35.23%		N/A
-42.82%		N/A
6.16%		N/A
99.83%		N/A
35,556.75%		N/A
190.46%		N/A
105.92%		N/A
53.91%		N/A
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/A-107.00
-94.26%		-60.60
43.36%		-19.70
67.49%		-9.00
54.31%		-4.30
52.22%		-4.05
5.81%		-2.93
27.65%		N/A
44.47%		N/A
55.17%		N/A
-23.43%		N/A
136.26%		N/A
205.47%		N/A
102.22%		N/A
53.29%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.36
41.06%		-0.33
55.89%		-0.30
-886.00%		-0.29
28.60%		-0.23
34.75%		-0.20
37.50%		-0.10
65.52%		-0.06
78.57%		0.03
113.04%
Revenue
Q2Q % growth		6.12M8.16M12.24M18.36M21.42M
250.00%		28.56M
250.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-14.66M
-16.83%		-14.636M
-21.96%		-15.142M
-10.49%		-14.499M
-8.79%		-5.923M
59.60%		-14.688M
-0.35%		-11.22M
25.90%		-7.956M
45.13%		-1.122M
81.06%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.40
51.81%		-0.38-0.02-5.28%
Q2 2024
Q2Q % growth		 -0.03
95.89%		-0.350.3291.47%
Q1 2024
Q2Q % growth		 -0.74
2.63%		-0.57-0.17-28.79%
Q4 2023
Q2Q % growth		 -0.61
-10.91%		-0.58-0.03-4.92%
Q3 2023
Q2Q % growth		 -0.83
35.16%		-0.54-0.29-55.00%
Q2 2023
Q2Q % growth		 -0.73
40.16%		-0.65-0.08-12.41%
Q1 2023
Q2Q % growth		 -0.76
24.00%		-0.880.1214.11%
Q4 2022
Q2Q % growth		 -0.55
38.89%		-1.100.5549.84%
Q3 2022
Q2Q % growth		 -1.28
-28.00%		-1.24-0.04-3.43%
Q2 2022
Q2Q % growth		 -1.22
-10.91%		-1.06-0.16-15.56%
Q1 2022
Q2Q % growth		 -1.00
23.08%		-1.020.021.96%
Q4 2021
Q2Q % growth		 -0.90
-28.57%		-1.050.1513.92%
Q3 2021
Q2Q % growth		 -1.00
33.33%		-1.120.1210.87%
Q2 2021
Q2Q % growth		 -1.10
57.69%		-1.170.075.95%
Q1 2021
Q2Q % growth		 -1.30
69.05%		-1.04-0.26-24.46%
Q4 2020
Q2Q % growth		 -0.70
78.79%		-1.490.7952.99%
Q3 2020
Q2Q % growth		 -1.50
64.29%		-2.040.5426.47%
Q2 2020
Q2Q % growth		 -2.60
43.48%		-3.020.4213.88%
Q1 2020
Q2Q % growth		 -4.20
44.74%		-3.54-0.66-18.78%
Q4 2019
Q2Q % growth		 -3.30
46.77%		-3.770.4712.56%
Q3 2019
Q2Q % growth		 -4.20
74.55%		-3.88-0.32-8.36%
Q2 2019
Q2Q % growth		 -4.60
72.78%		-7.092.4935.11%
Q1 2019
Q2Q % growth		 -7.60
63.81%		-7.55-0.05-0.69%
Q4 2018
Q2Q % growth		 -6.20 -10.204.0039.22%
Q3 2018
Q2Q % growth		 -16.50 -8.47-8.03-94.90%
Q2 2018
Q2Q % growth		 -16.90 -21.424.5221.10%
Q1 2018
Q2Q % growth		 -21.00 -20.40-0.60-2.94%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0.7% 9.89% 9.89%
RevenueN/A N/A N/A N/A